相关实验视频

Updated: May 20, 2025

Development of a Lateral Flow Immunochromatographic Strip for Rapid and Quantitative Detection of Small Molecule Compounds

Development of a Lateral Flow Immunochromatographic Strip for Rapid and Quantitative Detection of Small Molecule Compounds

Published on: November 13, 2021

增加侧流免疫试验的扭曲:从选择到应用,直接用螺旋性附属体取代抗体

Christy J Sadler^1,2, Adam Creamer^1,2, Kim Anh Giang³

¹Department of Materials, Department of Bioengineering, Institute of Biomedical Engineering Imperial College London, London SW7 2AZ, U.K.

Journal of the American Chemical Society

|March 26, 2025

概括

研究人员在侧流免疫试验中开发了附属体作为抗体的替代品. 这些附属体提供了更好的稳定性和性能,克服了诊断测试中的抗体限制.

科学领域:

生物技术和生物医学工程
蛋白质工程和分子识别

背景情况:

抗体对于横流免疫试验至关重要,但产生的变异性和稳定性较差.
抗体复制性和稳定性的局限性阻碍了强大的诊断工具的开发.

研究的目的:

在SARS-CoV-2侧流免疫试验中开发和验证亲体作为抗体的直接替代物.
与抗体相比,评估亲体的生理化学优势和性能.

主要方法:

菌体显示用于生成针对SARS-CoV-2尖端蛋白的附属体.
在侧流免疫试验中使用亲体,取代传统的抗体.
用分子动力学模拟来研究附体二极体特性和纳米粒子固定.

主要成果:

在侧流免疫试验中,亲体成功取代了抗体,显示出高性能.
与抗体相比,亲体表现出优越的热和湿度稳定性.
分子动力学揭示了体二极体的结构特征,使得有效的纳米粒子探测器设计成为可能.

结论:

在免疫测试中,亲体可以作为抗体的可行和直接替代品.
改善的生理化学特性和模块化设计使得它们成为诊断应用的有希望的替代品.

更多相关视频

Scalable High Throughput Selection From Phage-displayed Synthetic Antibody Libraries

Scalable High Throughput Selection From Phage-displayed Synthetic Antibody Libraries

Published on: January 17, 2015

Snap Chip for Cross-reactivity-free and Spotter-free Multiplexed Sandwich Immunoassays

Snap Chip for Cross-reactivity-free and Spotter-free Multiplexed Sandwich Immunoassays

Published on: November 13, 2017

相关概念视频

Enzyme-Linked Immunosorbent Assay

Enzyme-Linked Immunosorbent Assay

In 1971, Peter Perlman and Eva Engvall developed an Enzyme-linked immunosorbent assay (ELISA or EIA). ELISA differs from western blot in that the assays are conducted in microtiter plates or in vivo rather than on an absorbent membrane.
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen. Enzyme-substrate reaction allows the antigen to be visualized or...

Hybridoma Technology

Hybridoma Technology

Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...